Target intelligence / Profile preview

Major capsid protein VP1 (VP1)

Target
VP1
Molecular classification
Other
01

Overview

Major capsid protein VP1 is the principal structural component of the JC polyomavirus (JCPyV) capsid, forming pentameric capsomeres that assemble into an icosahedral shell. It plays a critical role in viral pathogenesis by mediating attachment to host cells through specific interactions with alpha-2,6-linked sialic acid on lactotetrasaccharide series C (LSTc). In immunocompromised individuals, JCPyV can reactivate and cause progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease of the central nervous system. VP1 is a major target for therapeutic intervention, including neutralizing monoclonal antibodies (such as GRE1) and virus-like particle (VLP) vaccines designed to block viral entry or elicit protective humoral immunity. However, mutations in the outer loops of VP1 frequently arise in PML patients, allowing the virus to evade antibody-mediated neutralization and presenting a significant challenge for drug development.

Other names
Major structural protein VP1Capsid protein VP1Viral protein 1JCV-VP1JCPyV-VP1
02

Mechanism of action

Neutralizing antibodies and small molecules bind to the outer loops or receptor-binding pockets of VP1, preventing its interaction with host cell receptors (such as LSTc) and thereby blocking viral attachment and entry. Active immunization with VP1-based vaccines or virus-like particles (VLPs) stimulates the production of host neutralizing antibodies to prevent or control infection.

03

Biological functions

Other
04

Disease associations

InfectionOther
05

Safety considerations

Immune evasion due to viral mutationsImmune reconstitution inflammatory syndrome (IRIS)Blood-brain barrier penetrationCross-reactivity with BK polyomavirus
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

Anti-JCV VP1 antibody titerJCV DNA in cerebrospinal fluid (CSF)JCV VP1 mutations

Beyond the preview

Go deeper on Major capsid protein VP1 (VP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major capsid protein VP1 (VP1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call